NEW YORK, July 05, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of TrueBlue, Inc. (NYSE: TBI) resulting from allegations that TrueBlue may have issued materially misleading business information to the investing public. SO WHAT: If you purchased TrueBlue securities you […]

Read More

NEW YORK, July 05, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Apyx Medical Corporation (NASDAQ: APYX) between May 12, 2021 and March 11, 2022, both dates inclusive (the “Class Period”), of the important August 5, 2022 lead plaintiff deadline. SO WHAT: If you purchased Apyx securities […]

Read More